Company Filing History:
Years Active: 2012
Title: Yoav Keynan: Innovator in Serotype Identification
Introduction
Yoav Keynan is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of molecular biology, particularly in the identification of serotypes through innovative methods.
Latest Patents
Keynan holds a patent related to a method of identifying a serotype, specifically utilizing polymerase chain reaction (PCR) primer sets. This method is designed according to a fragment of a capsular polysaccharide synthesis (cps) region to identify the K57 or NTUH-N1 serotype. The NTUH-N1 serotype is a novel discovery that differs from the previously reported 77 serotypes. His PCR-based cps genotyping method addresses the issues of insufficient specificity and sensitivity found in conventional immune methods. This innovative approach can be applied in clinical diagnosis, offering advantages such as rapidity and low cost. Additionally, it reduces the rate of unidentifiable strains.
Career Highlights
Keynan is affiliated with National Taiwan University, where he continues to advance research in his field. His work has garnered attention for its practical applications in clinical settings.
Collaborations
Keynan has collaborated with notable colleagues, including Jin-Town Wang and Yi-Jiun Pan, contributing to the advancement of research in serotype identification.
Conclusion
Yoav Keynan's innovative methods in serotype identification represent a significant advancement in molecular biology. His contributions are poised to enhance clinical diagnostics and improve patient outcomes.